Key facts
- Hippocratic AI’s last known valuation is $3.5B (Nov 2025).
- It has raised $404.0M; the latest was Later Stage VC ($126.0M) in Nov 2025.
- Notable investors include Andreessen Horowitz, General Catalyst, SV Angel, Greycroft, Kleiner Perkins — 26 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 26 names
- ·Watchlist + deal alerts for Hippocratic AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Hippocratic AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hippocratic AI
Developer of a healthcare platform intended to improve healthcare accessibility and health outcomes worldwide. The company's platform helps develop safe artificial health general intelligence to improve healthcare accessibility and fitness outcomes, enabling patients to get healthcare at home and improve their health without any hassle
- Sector
- Healthcare
- HQ
- Palo Alto, CA, United States
- Founded
- 2023
- Employees
- 190
- Website
- hippocraticai.com/
- Ownership
- Privately Held (backing)
Hippocratic AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hippocratic AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hippocratic AI in its N-PORT filings yet. We sweep new filings monthly.